MD Anderson President Changing Roles
Family Matters - Winter 2011
John Mendelsohn, M.D., who has served as president of The University of Texas MD Anderson Cancer Center through an incredibly productive period of nearly 15 years, recently announced plans to relinquish his leadership position when a new president is recruited and in place.
Mendelsohn will remain on the MD Anderson faculty, returning to clinical and translational research as co-director of its new Institute for Personalized Cancer Therapy (IPCT). Gordon Mills, M.D., Ph.D., who also chairs MD Anderson’s Department of Systems Biology, will co-direct the institute, which is designed to carry out research revolutionizing the way cancer treatment is delivered.
“I’ve had the best job imaginable, working with amazing faculty, administrators and all employees, along with our many volunteers and supporters in the community. I am grateful for the opportunity I’ve had to serve as their leader at MD Anderson, which is now well recognized as first in the nation in translational and clinical research and the nation’s number one hospital caring for cancer patients,” Mendelsohn said. “So much has been accomplished, but much more remains to be done. I am confident MD Anderson will continue to lead that worldwide effort.”
Mendelsohn is only the third president of MD Anderson in a history that spans 70 years. R. Lee Clark, M.D. served as president from 1946-1978, and was followed by Charles A. LeMaistre, M.D., who was president from 1978-1996, when Mendelsohn arrived to take charge. Ernst W. Bertner, M.D. was initial acting director, from 1942 to 1946.